DePuy Launches New Interbody Implant For Degenerative Disc Disease

The new implant was specifically designed to simplify key stages of spinal fusion surgery to help restore spinal disc height between two vertebrae.

DePuy Synthes, an orthopedic and neurosurgery company owned by Johnson & Johnson, recently announced the launch of their new flagship technology, the CONCORDE LIFT Interbody Implant. The new implantable device was designed to help treat patients suffering from degenerative disc disease, a condition that can cause extreme pain from a damaged disc in the spine.

The implantable device was designed as part of a new procedural solution that can simplify minimally invasive spine surgery procedures used to help restore disc height in the spinal column. This is typically done through the process of spinal fusion, a surgical procedure that places bone or bone-like material within the space between two spinal vertebrae. In an effort to simplify the procedure, DePuy created the CONCORDE LIFT implant to provide patients with a device that can specifically fit each patient’s anatomy due to a continuous expansion mechanism.

“To help treat patients suffering from advanced degenerative disc disease, the degenerated disc is first removed, and then the CONCORDE LIFT Expandable Interbody device is inserted and expanded, with the procedural aim of restoring height of the disc space,” said Nadav Tomer, worldwide president of DePuy Synthes. “The device is an expandable titanium cage with instrumentation that delivers control and performance to clinicians through tactile feedback and reliable graft delivery. It is designed with a continuous expansion mechanism, which allows the surgeon to specifically fit the intervertebral cage to the patient’s anatomy, creating a more personalized solution.”

Perhaps the most novel part of the technology comes after the implant is inserted and the surgeon creates the necessary expansion. After implantation, the device can then be backfilled with bone graft to maximize bone graft contact and containment, which will help promote bone growth and increase the chances of successful spinal fusion.

By Kristopher Sturgis | MD+DI

Image Credit: DePuy Synthes

READ MORE

Avatar
About Peter Coffaro 646 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the orthopedic industry. Recognized by MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager and Distributor. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy and Stryker. He is also the founder of OrthoFeed: a popular blog that covers orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing and professional education. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.